Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
갑상선 결절 환자에서 혈청 갑상선자극호르몬 수치와 고분화 갑상선암과의 연관성에 관한 분석Preoperative Thyroid-stimulating Hormone Levels as a Predictor of Thyroid Carcinoma
- Other Titles
- Preoperative Thyroid-stimulating Hormone Levels as a Predictor of Thyroid Carcinoma
- Issue Date
- 2010
- Publisher
- 대한갑상선-내분비외과학회
- Keywords
- Thyroid carcinoma; Thyroid stimulating hormone; Differentiated thyroid cancer; 갑상선암; 갑상선자극호르몬; 분화갑상선암
- Citation
- The Journal of Endocrine Surgery, v.10, no.4, pp.220 - 223
- Indexed
- KCI
OTHER
- Journal Title
- The Journal of Endocrine Surgery
- Volume
- 10
- Number
- 4
- Start Page
- 220
- End Page
- 223
- ISSN
- 2508-8149
- Abstract
- Purpose: This study investigated the effects of serum thyroid-stimulating hormone (TSH) levels in predicting malignancy-associated differentiated thyroid cancer (DTC) and benign thyroid nodules. Methods: Between January 2005 and December 2007, 346 patients underwent thyroid surgery at one hospital. Their records were retrospectively reviewed. Results: Sixty-nine percent (237 of 346) of the patients had DTC. The mean preoperative TSH level was higher than in the malignant group (5 uIU/ml vs 0.4 uIU/ml). The rate of malignancy was the 71% in patients with TSH levels ＞5 uIU/ml. The TSH level of DTC with metastasis of the lymph node was higher than that with non-metastasis (3.08 uIU/ml vs 2.09 uIU/ml, P＜0.01)Conclusion: The likelihood of DTC increases with higher serum TSH concentration. Serum TSH level might be useful in predicting malignant nodular thyroid lesion. (Korean J Endocrine Surg 2010;10:220-223)
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.